Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B A van Doorn

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 13, 2020
[A woman with bumps in the eyebrows]D Wang, J Damman, M B A van Doorn
Journal of the European Academy of Dermatology and Venereology : JEADV|October 30, 2014
A fistula in disguise--a case reportP Smit, D C M S Wiryasaputra, M B A van Doorn
Nederlands Tijdschrift Voor Geneeskunde|January 13, 2018
[A man with severe skin rash]T V Nguyen, G L van Rooijen, M B A van Doorn
Journal of the European Academy of Dermatology and Venereology : JEADV|January 21, 2017
Non-invasive anaesthetic methods for dermatological laser procedures: a systematic reviewK Greveling, E P Prens, L Liu, et al.
The British Journal of Dermatology|December 1, 2015
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the noseK Greveling, K de Vries, M B A van Doorn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2016
Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatmentK Greveling, Th van der Klok, M B A van Doorn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2014
Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategiesJ-M Carrascosa, M B A van Doorn, M Lahfa, et al.
British Journal of Clinical Pharmacology|June 8, 2018
A systematic literature review of the human skin microbiome as biomarker for dermatological drug developmentT Niemeyer-van der Kolk, H E C van der Wall, C Balmforth, et al.
The British Journal of Dermatology|December 1, 2015
Recurrence rate of lentigo maligna after micrographically controlled staged surgical excisionK de Vries, K Greveling, L M Prens, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2018
Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkersA R J V Vossen, H H van der Zee, N Davelaar, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|May 13, 2020
[A woman with bumps in the eyebrows]D Wang, J Damman, M B A van Doorn
Journal of the European Academy of Dermatology and Venereology : JEADV|October 30, 2014
A fistula in disguise--a case reportP Smit, D C M S Wiryasaputra, M B A van Doorn
Nederlands Tijdschrift Voor Geneeskunde|January 13, 2018
[A man with severe skin rash]T V Nguyen, G L van Rooijen, M B A van Doorn
Journal of the European Academy of Dermatology and Venereology : JEADV|January 21, 2017
Non-invasive anaesthetic methods for dermatological laser procedures: a systematic reviewK Greveling, E P Prens, L Liu, et al.
The British Journal of Dermatology|December 1, 2015
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the noseK Greveling, K de Vries, M B A van Doorn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2016
Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatmentK Greveling, Th van der Klok, M B A van Doorn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2014
Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategiesJ-M Carrascosa, M B A van Doorn, M Lahfa, et al.
British Journal of Clinical Pharmacology|June 8, 2018
A systematic literature review of the human skin microbiome as biomarker for dermatological drug developmentT Niemeyer-van der Kolk, H E C van der Wall, C Balmforth, et al.
The British Journal of Dermatology|December 1, 2015
Recurrence rate of lentigo maligna after micrographically controlled staged surgical excisionK de Vries, K Greveling, L M Prens, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2018
Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkersA R J V Vossen, H H van der Zee, N Davelaar, et al.
Pageof 2